Logo Image
News
FDA UpdatesLaw and AdvocacyTechnology TrendsViewpointsAll News
Media
In-Depth InsightsPharmacist ViewScript-EdExpert InterviewsPharmacy PerspectivesPodcastsShorts
Conferences
Conference CoverageConference Listing
Resources
Disease Awareness White Board VideoAmerican Pharmacists MonthSponsored ResourcesCME/CEPartners
More
Publications
Drug Topics JournalTotal Pharmacy JournalSubmission of ArticlesSupplements And Featured Publications
Events
Virtual EventsTotal Pharmacy Solutions Summit
Business
Business StrategiesPatient ServicesPharmacy InventoryLaw and RegulationsTechnology and DataAll Business News
Practice Type
Independent PharmacyChain PharmacySpecialty PharmacyHealth System PharmacyPharmacy Technicians
Total Pharmacy

Subscribe

  • News
  • Media
  • Conferences
  • Resources
  • Publications
  • Events
  • Business
  • Practice Type
  • Subscribe
  • Total Pharmacy
  • Allergy
  • Asthma
  • Autoimmune Diseases
  • Biosimilars
  • COVID-19
  • Cannabidiol (CBD)
  • Cardiology
  • Compounding
  • Continuous Glucose Monitoring
  • Dermatology
  • Diabetes
  • Digestive Health
  • Endocrinology
  • Eye Health
  • Generics
  • HIV
  • Headache and Migraine
  • Immunization
  • Infectious Disease
  • Influenza
  • Insulin Management
  • Medical Devices
  • Mental and Behavioral Health
  • Neurology
  • OTC
  • Obesity Management
  • Oncology
  • Pain Management
    • Nonopioid Pain Management
  • Pediatrics
  • Pneumococcal
  • Public Health
  • Rare Diseases
  • Respiratory
  • Rheumatology
  • Shingles
  • Specialty Pharmacy
  • Substance Use Disorder
  • Technology and Data
  • Veterinary Pharmacy
  • Women's Health
  • Wound Care Awareness
Spotlight -
ASHP Midyear |
FDA Updates|
Total Pharmacy
Advertisement

Marrium Z. Qureshi, PharmD

Advertisement

Articles by Marrium Z. Qureshi, PharmD

FDA

FDA Approves Belumosudil (Rezurock) for the Treatment of Patients with Chronic Graft-Versus-Host Disease (cGVHD)

ByMarrium Z. Qureshi, PharmD,Kevin W. Chamberlin, PharmD
October 27th 2021
Advertisement

Latest Updated Articles



    Advertisement
    Advertisement

    Trending on Drug Topics

    1

    FDA Approves Utebzi as First Oral Carbapenem for Complicated UTIs

    2

    Heat and Pregnancy: What Pharmacists Need to Know

    3

    PBM Audits Target Pharmacies for Compliance, Revenue Recovery

    4

    Q&A: PBMs Use Audits to Generate Revenue Amid Unprecedented Scrutiny

    5

    "It is the Core of Our Oath:" Why Gender-Affirming Care Is a Fundamental Pharmacy Mandate

    • About
    • Advertise
    • Editorial
    • Editorial Board
    • Contact Us
    • Terms and Conditions
    • Privacy
    • Do Not Sell My Personal Information
    Contact Info

    259 Prospect Plains Rd, Bldg H
    Cranbury, NJ 08512

    • AdvanCE
    • Total Pharmacy
    Drug Topics
    Brand Logo

    © 2026 MJH Life Sciences®

    All rights reserved.

    Home
    About Us
    News
    Contact Us